3-(2,2,2-trimethylhydrazine)propionate and oxidopamine

3-(2,2,2-trimethylhydrazine)propionate has been researched along with oxidopamine in 2 studies

Compound Research Comparison

Studies (3-(2,2,2-trimethylhydrazine)propionate)	Trials (3-(2,2,2-trimethylhydrazine)propionate)	Recent Studies (post-2010) (3-(2,2,2-trimethylhydrazine)propionate)	Studies (oxidopamine)	Trials (oxidopamine)	Recent Studies (post-2010) (oxidopamine)
251	35	105	8,630	6	2,407

Protein Interaction Comparison

Protein	Taxonomy	3-(2,2,2-trimethylhydrazine)propionate (IC50)	oxidopamine (IC50)
Glyceraldehyde-3-phosphate dehydrogenase	Homo sapiens (human)		8
DNA repair protein RAD52 homolog	Homo sapiens (human)		0.779

Research

Studies (2)

Timeframe	Studies, this research(%)	All Research%
pre-1990	0 (0.00)	18.7374
1990's	0 (0.00)	18.2507
2000's	0 (0.00)	29.6817
2010's	2 (100.00)	24.3611
2020's	0 (0.00)	2.80

Authors

Authors	Studies
Beitnere, U; Dzirkale, Z; Isajevs, S; Jansone, B; Kalvinsh, I; Klusa, VZ; Muceniece, R; Pupure, J; Rumaks, J; Svirina, D; Svirskis, S; Vinters, HV	1
Beitnere, U; Isajeva, D; Isajevs, S; Jansone, B; Kalvinsh, I; Klusa, V	1

Other Studies

2 other study(ies) available for 3-(2,2,2-trimethylhydrazine)propionate and oxidopamine

Article	Year
Neuroprotective properties of mildronate, a small molecule, in a rat model of Parkinson's disease. International journal of molecular sciences, 2010, Nov-09, Volume: 11, Issue:11 Topics: Animals; Biomarkers; Calcium-Binding Proteins; Corpus Striatum; Glial Fibrillary Acidic Protein; Male; Methylhydrazines; Microfilament Proteins; Neuroglia; Neurons; Neuroprotective Agents; Nitric Oxide Synthase Type II; Oxidopamine; Parkinson Disease, Secondary; Rats; Rats, Wistar; Receptor, Notch3; Receptors, Notch; Substantia Nigra; Tyrosine 3-Monooxygenase	2010
Mildronate as a regulator of protein expression in a rat model of Parkinson's disease. Medicina (Kaunas, Lithuania), 2011, Volume: 47, Issue:10 Topics: Animals; Cardiovascular Agents; Corpus Striatum; Disease Models, Animal; Glial Cell Line-Derived Neurotrophic Factor; HSP70 Heat-Shock Proteins; Male; Methylhydrazines; Neural Cell Adhesion Molecules; Neuroprotective Agents; Oxidopamine; Parkinson Disease, Secondary; Protein Biosynthesis; Rats; Rats, Wistar; Substantia Nigra	2011

Article

Year

Neuroprotective properties of mildronate, a small molecule, in a rat model of Parkinson's disease.

International journal of molecular sciences, 2010, Nov-09, Volume: 11, Issue:11

Topics: Animals; Biomarkers; Calcium-Binding Proteins; Corpus Striatum; Glial Fibrillary Acidic Protein; Male; Methylhydrazines; Microfilament Proteins; Neuroglia; Neurons; Neuroprotective Agents; Nitric Oxide Synthase Type II; Oxidopamine; Parkinson Disease, Secondary; Rats; Rats, Wistar; Receptor, Notch3; Receptors, Notch; Substantia Nigra; Tyrosine 3-Monooxygenase

2010

Mildronate as a regulator of protein expression in a rat model of Parkinson's disease.

Medicina (Kaunas, Lithuania), 2011, Volume: 47, Issue:10

Topics: Animals; Cardiovascular Agents; Corpus Striatum; Disease Models, Animal; Glial Cell Line-Derived Neurotrophic Factor; HSP70 Heat-Shock Proteins; Male; Methylhydrazines; Neural Cell Adhesion Molecules; Neuroprotective Agents; Oxidopamine; Parkinson Disease, Secondary; Protein Biosynthesis; Rats; Rats, Wistar; Substantia Nigra

2011